Mitosol Kit
NDC 49771-002
Product Information
Mitosol (mitomycin) is a NDA-approved product labeled by Mobius Therapeutics Llc. Mitomycin is used to treat various types of cancer (such as stomach/pancreas cancer). It is supplied as a kit. This product entry covers the primary NDC 49771-002 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 49771-002?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- MITOMYCIN (UNII: 50SG953SK6)
- MITOMYCIN (UNII: 50SG953SK6) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- MANNITOL (UNII: 3OWL53L36A)
- WATER (UNII: 059QF0KO0R)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 1244553 - mitoMYcin 0.2 MG/ML Ophthalmic Solution
- RxCUI: 1244553 - mitomycin 0.2 MG/ML Ophthalmic Solution
- RxCUI: 1244558 - Mitosol 0.2 MG/ML Ophthalmic Solution
- RxCUI: 1244558 - mitomycin 0.2 MG/ML Ophthalmic Solution [Mitosol]
* Please review the full disclaimer at the bottom of this page.